EA201591098A1 - Бициклические пиримидиновые соединения - Google Patents
Бициклические пиримидиновые соединенияInfo
- Publication number
- EA201591098A1 EA201591098A1 EA201591098A EA201591098A EA201591098A1 EA 201591098 A1 EA201591098 A1 EA 201591098A1 EA 201591098 A EA201591098 A EA 201591098A EA 201591098 A EA201591098 A EA 201591098A EA 201591098 A1 EA201591098 A1 EA 201591098A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pyrimidine compounds
- bicyclic pyrimidine
- group
- compounds
- bicyclic
- Prior art date
Links
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical class C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102100021977 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Human genes 0.000 abstract 1
- 108050004000 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Proteins 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
Abstract
В изобретении предложены соединения формулы Iгде X представляет собой связь или CH; R выбран из группы, состоящей изкаждый Rи Rнезависимо выбран из группы, состоящей из СН и N; Rпредставляет собой Н или СН; Rпредставляет собой Н или СН; L выбран из группы, состоящей из -O(CH)-, -C(O)NH(CH)-, -CHC(O)NH(CH)-, -(CH)N(C(O)CH)CH-, -(CH)N(C(O)CH)CH-, -(CH)NH-, (CH)OCH-, -(CH)-, -(CH)NHCH-, -(CH)O- и -CHO(CH)-; или их фармацевтически приемлемые соли. Соединения согласно изобретению являются ингибиторами аутотаксина.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361751363P | 2013-01-11 | 2013-01-11 | |
| US201361777201P | 2013-03-12 | 2013-03-12 | |
| PCT/US2014/010400 WO2014110000A1 (en) | 2013-01-11 | 2014-01-07 | Pyrido- or pyrrolo-fused pyrimidine derivatives as autotaxin inhibitors for treating pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201591098A1 true EA201591098A1 (ru) | 2015-11-30 |
| EA025106B1 EA025106B1 (ru) | 2016-11-30 |
Family
ID=50031555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201591098A EA025106B1 (ru) | 2013-01-11 | 2014-01-07 | Бициклические пиримидиновые соединения |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8969555B2 (ru) |
| EP (1) | EP2943494B1 (ru) |
| JP (1) | JP6285461B2 (ru) |
| KR (1) | KR101757997B1 (ru) |
| CN (1) | CN104903327B (ru) |
| AU (1) | AU2014205642B2 (ru) |
| BR (1) | BR112015015812A2 (ru) |
| CA (1) | CA2893253C (ru) |
| EA (1) | EA025106B1 (ru) |
| ES (1) | ES2636248T3 (ru) |
| MX (1) | MX2015008971A (ru) |
| TW (1) | TWI499591B (ru) |
| WO (1) | WO2014110000A1 (ru) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201500356A (zh) * | 2013-04-12 | 2015-01-01 | Lilly Co Eli | 二氫吡啶并嘧啶化合物 |
| SI3071561T1 (sl) | 2013-11-22 | 2021-11-30 | Sabre Therapeutics Llc | Spojine, ki inhibirajo avtotaksin |
| US9051320B1 (en) | 2014-08-18 | 2015-06-09 | Pharmakea, Inc. | Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor |
| GB201501870D0 (en) | 2015-02-04 | 2015-03-18 | Cancer Rec Tech Ltd | Autotaxin inhibitors |
| GB201502020D0 (en) | 2015-02-06 | 2015-03-25 | Cancer Rec Tech Ltd | Autotaxin inhibitory compounds |
| AU2016268250B2 (en) | 2015-05-27 | 2020-08-27 | Sabre Therapeutics Llc | Autotaxin inhibitors and uses thereof |
| WO2016197009A1 (en) | 2015-06-05 | 2016-12-08 | Vertex Pharmaceuticals Incorporated | Triazoles for the treatment of demyelinating diseases |
| WO2018106643A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Heterocyclic azoles for the treatment of demyelinating diseases |
| WO2018106641A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Pyrazoles for the treatment of demyelinating diseases |
| WO2018106646A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Aminotriazoles for the treatment of demyelinating diseases |
| US10961242B2 (en) | 2017-05-17 | 2021-03-30 | Legochem Biosciences, Inc. | Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same |
| KR101798840B1 (ko) | 2017-05-17 | 2017-11-17 | 주식회사 레고켐 바이오사이언스 | 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물 |
| EP3805234B1 (en) * | 2018-05-24 | 2024-09-04 | Guangzhou Henovcom Bioscience Co., Ltd. | Aromatic heterocyclic compound, and pharmaceutical composition and use thereof |
| WO2020018596A1 (en) * | 2018-07-16 | 2020-01-23 | The Scripps Research Institute | Opioid haptens, conjugates, vaccines, and methods of generating antibodies |
| AU2020213569B2 (en) * | 2019-02-01 | 2022-10-13 | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company | Pyrrolopyrimidine derivative and use thereof |
| JP7389238B2 (ja) * | 2019-09-06 | 2023-11-29 | 武漢人福創新薬物研発中心有限公司 | ピリミジン化合物及びその調製方法 |
| AU2020349516A1 (en) * | 2019-09-17 | 2022-03-17 | Bial-R&D Investments, S.A. | Substituted imidazole carboxamides and their use in the treatment of medical disorders |
| CN112778334B (zh) * | 2019-11-07 | 2022-04-15 | 广州市恒诺康医药科技有限公司 | 芳杂环化合物、其药物组合物及其应用 |
| JP2023505419A (ja) * | 2019-12-11 | 2023-02-09 | スーチョワン ハイスコ ファーマスーティカル カンパニー リミテッド | 含窒素ヘテロ環式オートタキシン阻害薬及びそれを含有する組成物並びにその使用 |
| CN113943295A (zh) * | 2020-07-16 | 2022-01-18 | 武汉人福创新药物研发中心有限公司 | 吡咯并嘧啶类化合物及其用途 |
| CN113943296A (zh) * | 2020-07-16 | 2022-01-18 | 武汉人福创新药物研发中心有限公司 | 吡咯并嘧啶衍生物及其应用 |
| JP2023535846A (ja) * | 2020-07-28 | 2023-08-21 | 武漢人福創新薬物研発中心有限公司 | 含窒素複素環化合物の塩及びその塩の固体形態、医薬組成物並びに用途 |
| WO2022022569A1 (zh) * | 2020-07-28 | 2022-02-03 | 武汉人福创新药物研发中心有限公司 | 含氮杂环化合物的固体形式及其药物组合物和用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1071301A (en) * | 1999-11-01 | 2001-05-14 | Eli Lilly And Company | Pharmaceutical compounds |
| AU2003242252A1 (en) | 2002-06-07 | 2003-12-22 | Kyowa Hakko Kogyo Co., Ltd. | Bicyclic pyrimidine derivatives |
| DE102004020908A1 (de) * | 2004-04-28 | 2005-11-17 | Grünenthal GmbH | Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen |
| CA2606760C (en) * | 2005-05-04 | 2014-12-23 | Renovis, Inc. | Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and disfunctions |
| MX2011005720A (es) * | 2008-12-01 | 2011-06-17 | Merck Patent Gmbh | Pirido [4,3-d] pirimidinas 2,5-diamino sustituidas como inhibidores de autotaxina contra cancer. |
| WO2012009258A2 (en) * | 2010-07-13 | 2012-01-19 | Edward Roberts | Peptidomimetic galanin receptor modulators |
| CN103201262B (zh) | 2010-08-20 | 2016-06-01 | 艾米拉医药股份有限公司 | 自分泌运动因子抑制剂及其用途 |
| WO2012085167A1 (en) * | 2010-12-22 | 2012-06-28 | Merz Pharma Gmbh & Co. Kgaa | Metabotropic glutamate receptor modulators |
| WO2013054185A1 (en) * | 2011-10-13 | 2013-04-18 | Pfizer, Inc. | Pyrimidine and pyridine derivatives useful in therapy |
| ES2748656T3 (es) * | 2011-10-28 | 2020-03-17 | Inhibitaxin Ltd | Derivados de piridazina útiles en terapia |
| TW201520219A (zh) * | 2013-03-12 | 2015-06-01 | Lilly Co Eli | 咪唑並吡啶化合物 |
| TW201500356A (zh) * | 2013-04-12 | 2015-01-01 | Lilly Co Eli | 二氫吡啶并嘧啶化合物 |
-
2013
- 2013-12-30 TW TW102149122A patent/TWI499591B/zh active
-
2014
- 2014-01-07 WO PCT/US2014/010400 patent/WO2014110000A1/en active Application Filing
- 2014-01-07 AU AU2014205642A patent/AU2014205642B2/en not_active Ceased
- 2014-01-07 ES ES14702336.0T patent/ES2636248T3/es active Active
- 2014-01-07 EP EP14702336.0A patent/EP2943494B1/en active Active
- 2014-01-07 BR BR112015015812A patent/BR112015015812A2/pt not_active IP Right Cessation
- 2014-01-07 US US14/148,775 patent/US8969555B2/en active Active
- 2014-01-07 CA CA2893253A patent/CA2893253C/en not_active Expired - Fee Related
- 2014-01-07 JP JP2015552726A patent/JP6285461B2/ja not_active Expired - Fee Related
- 2014-01-07 EA EA201591098A patent/EA025106B1/ru not_active IP Right Cessation
- 2014-01-07 CN CN201480004482.6A patent/CN104903327B/zh not_active Expired - Fee Related
- 2014-01-07 MX MX2015008971A patent/MX2015008971A/es unknown
- 2014-01-07 KR KR1020157018295A patent/KR101757997B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150092761A (ko) | 2015-08-13 |
| CN104903327B (zh) | 2016-09-07 |
| MX2015008971A (es) | 2015-09-28 |
| BR112015015812A2 (pt) | 2017-07-11 |
| CN104903327A (zh) | 2015-09-09 |
| EP2943494A1 (en) | 2015-11-18 |
| ES2636248T3 (es) | 2017-10-05 |
| CA2893253A1 (en) | 2014-07-17 |
| AU2014205642B2 (en) | 2016-02-25 |
| AU2014205642A1 (en) | 2015-07-02 |
| TWI499591B (zh) | 2015-09-11 |
| TW201437209A (zh) | 2014-10-01 |
| WO2014110000A1 (en) | 2014-07-17 |
| CA2893253C (en) | 2017-11-28 |
| KR101757997B1 (ko) | 2017-07-13 |
| JP2016505010A (ja) | 2016-02-18 |
| EP2943494B1 (en) | 2017-02-22 |
| EA025106B1 (ru) | 2016-11-30 |
| JP6285461B2 (ja) | 2018-02-28 |
| US8969555B2 (en) | 2015-03-03 |
| US20140200231A1 (en) | 2014-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201591098A1 (ru) | Бициклические пиримидиновые соединения | |
| CY1121694T1 (el) | Ενωσεις δι-κυκλικου-συντηγμενου ετεροαρυλιου ή αρυλιου και η χρηση αυτων ως αναστολεις irak4 | |
| CY1120705T1 (el) | Καινοφανεις αναστολεις αποακετυλασων ιστονων | |
| EA201591486A1 (ru) | Соединения имидазопиридина | |
| CY1120480T1 (el) | Ενωσεις πυραζολοπυριμιδινης | |
| MX372962B (es) | Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca). | |
| EA201490949A1 (ru) | Ингибиторы киназ | |
| EA201891024A1 (ru) | Соединения-ингибиторы tank-связывающей киназы | |
| EA201691799A1 (ru) | Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa) | |
| AR095039A1 (es) | Inhibidores quinazolínicos de formas mutadas activantes del receptor del factor de crecimiento epidérmico | |
| EA201590534A1 (ru) | Новые бициклические производные | |
| CR20150418A (es) | Compuestos de tetrahidropirrolotiazina | |
| EA201691625A1 (ru) | Ароматические гетероциклические соединения как противовоспалительные соединения | |
| EA201692203A1 (ru) | Соединения, ингибирующие tank-связывающую киназу | |
| EA201591634A1 (ru) | Дигидропиридопиримидиновые соединения | |
| EA201590224A1 (ru) | Имидазотриазинкарбонитрилы, используемые в качестве ингибиторов киназы | |
| EA201490567A1 (ru) | Новые бициклические производные дигидрохинолин-2-она | |
| CR20140084A (es) | Derivados de 2-amino-4-(piridin-2-il)-5,6-dihidro-4h-1,3-oxazina y su uso como inhibidores de bace-1 y/o bace-2 | |
| EA201791684A1 (ru) | Селективные ингибиторы bace1 | |
| RS54730B1 (sr) | Inhibitori beta sekretaze | |
| CY1117688T1 (el) | Ενωσεις τετραϋδροπυρρολοθειαζινης | |
| EA201590319A1 (ru) | Новые бициклические пиридиноны | |
| EA201591360A1 (ru) | Азабензимидазолы в качестве ингибиторов изозимов фдэ4 для лечения цнс и других расстройств | |
| CO2019005165A2 (es) | Compuesto de piridona como inhibidor de c-met | |
| CL2019001694A1 (es) | Compuestos de pirazolopirimidina y métodos de uso de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |